These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 23332363)

  • 1. Epigenetic mechanisms in multiple sclerosis: implications for pathogenesis and treatment.
    Huynh JL; Casaccia P
    Lancet Neurol; 2013 Feb; 12(2):195-206. PubMed ID: 23332363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis.
    Casaccia-Bonnefil P; Pandozy G; Mastronardi F
    Prog Neurobiol; 2008 Dec; 86(4):368-78. PubMed ID: 18930111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic Modifications and Therapy in Multiple Sclerosis.
    Aslani S; Jafari N; Javan MR; Karami J; Ahmadi M; Jafarnejad M
    Neuromolecular Med; 2017 Mar; 19(1):11-23. PubMed ID: 27382982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis.
    Koch MW; Metz LM; Kovalchuk O
    Trends Mol Med; 2013 Jan; 19(1):23-30. PubMed ID: 23153574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential role of epigenetic modifications in the heritability of multiple sclerosis.
    Zhou Y; Simpson S; Holloway AF; Charlesworth J; van der Mei I; Taylor BV
    Mult Scler; 2014 Feb; 20(2):135-40. PubMed ID: 24493701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Updated Review of Epigenetic-Related Mechanisms and their Contribution to Multiple Sclerosis Disease.
    Eslahi M; Nematbakhsh N; Dastmalchi N; Teimourian S; Safaralizadeh R
    CNS Neurol Disord Drug Targets; 2023; 22(3):381-393. PubMed ID: 35043771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic insights into multiple sclerosis disease progression.
    Kular L; Jagodic M
    J Intern Med; 2020 Jul; 288(1):82-102. PubMed ID: 32614160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic modifications in brain and immune cells of multiple sclerosis patients.
    Castro K; Casaccia P
    Mult Scler; 2018 Jan; 24(1):69-74. PubMed ID: 29307300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The tale of histone modifications and its role in multiple sclerosis.
    He H; Hu Z; Xiao H; Zhou F; Yang B
    Hum Genomics; 2018 Jun; 12(1):31. PubMed ID: 29933755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic aspects of multiple sclerosis and future therapeutic options.
    Jamebozorgi K; Rostami D; Pormasoumi H; Taghizadeh E; Barreto GE; Sahebkar A
    Int J Neurosci; 2021 Jan; 131(1):56-64. PubMed ID: 32075477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic research in multiple sclerosis: progress, challenges, and opportunities.
    Zheleznyakova GY; Piket E; Marabita F; Pahlevan Kakhki M; Ewing E; Ruhrmann S; Needhamsen M; Jagodic M; Kular L
    Physiol Genomics; 2017 Sep; 49(9):447-461. PubMed ID: 28754822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel multiple sclerosis susceptibility loci implicated in epigenetic regulation.
    Andlauer TF; Buck D; Antony G; Bayas A; Bechmann L; Berthele A; Chan A; Gasperi C; Gold R; Graetz C; Haas J; Hecker M; Infante-Duarte C; Knop M; Kümpfel T; Limmroth V; Linker RA; Loleit V; Luessi F; Meuth SG; Mühlau M; Nischwitz S; Paul F; Pütz M; Ruck T; Salmen A; Stangel M; Stellmann JP; Stürner KH; Tackenberg B; Then Bergh F; Tumani H; Warnke C; Weber F; Wiendl H; Wildemann B; Zettl UK; Ziemann U; Zipp F; Arloth J; Weber P; Radivojkov-Blagojevic M; Scheinhardt MO; Dankowski T; Bettecken T; Lichtner P; Czamara D; Carrillo-Roa T; Binder EB; Berger K; Bertram L; Franke A; Gieger C; Herms S; Homuth G; Ising M; Jöckel KH; Kacprowski T; Kloiber S; Laudes M; Lieb W; Lill CM; Lucae S; Meitinger T; Moebus S; Müller-Nurasyid M; Nöthen MM; Petersmann A; Rawal R; Schminke U; Strauch K; Völzke H; Waldenberger M; Wellmann J; Porcu E; Mulas A; Pitzalis M; Sidore C; Zara I; Cucca F; Zoledziewska M; Ziegler A; Hemmer B; Müller-Myhsok B
    Sci Adv; 2016 Jun; 2(6):e1501678. PubMed ID: 27386562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific hypomethylation programs underpin B cell activation in early multiple sclerosis.
    Ma Q; Caillier SJ; Muzic S; ; Wilson MR; Henry RG; Cree BAC; Hauser SL; Didonna A; Oksenberg JR
    Proc Natl Acad Sci U S A; 2021 Dec; 118(51):. PubMed ID: 34911760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of differential DNA methylation associated with multiple sclerosis: A family-based study.
    Garcia-Manteiga JM; Clarelli F; Bonfiglio S; Mascia E; Giannese F; Barbiera G; Guaschino C; Sorosina M; Santoro S; Protti A; Martinelli V; Cittaro D; Lazarevic D; Stupka E; Filippi M; Esposito F; Martinelli-Boneschi F
    J Neuroimmunol; 2021 Jul; 356():577600. PubMed ID: 33991750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal methylome reveals CREB-associated neuro-axonal impairment in multiple sclerosis.
    Kular L; Needhamsen M; Adzemovic MZ; Kramarova T; Gomez-Cabrero D; Ewing E; Piket E; Tegnér J; Beck S; Piehl F; Brundin L; Jagodic M
    Clin Epigenetics; 2019 May; 11(1):86. PubMed ID: 31146783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics in Multiple Sclerosis.
    Chan VS
    Adv Exp Med Biol; 2020; 1253():309-374. PubMed ID: 32445101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic changes in neurology: DNA methylation in multiple sclerosis.
    Iridoy Zulet M; Pulido Fontes L; Ayuso Blanco T; Lacruz Bescos F; Mendioroz Iriarte M
    Neurologia; 2017 Sep; 32(7):463-468. PubMed ID: 25976949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric Multiple Sclerosis: Genes, Environment, and a Comprehensive Therapeutic Approach.
    Cappa R; Theroux L; Brenton JN
    Pediatr Neurol; 2017 Oct; 75():17-28. PubMed ID: 28843454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The emerging role of lncRNAs in multiple sclerosis.
    Ghaderian S; Shomali N; Behravesh S; Danbaran GR; Hemmatzadeh M; Aslani S; Jadidi-Niaragh F; Hosseinzadeh R; Torkamandi S; Mohammadi H
    J Neuroimmunol; 2020 Oct; 347():577347. PubMed ID: 32745803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomics and new targets for multiple sclerosis.
    Baranzini SE; Oksenberg JR
    Pharmacogenomics; 2005 Mar; 6(2):151-61. PubMed ID: 15882133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.